Report Detail

Pharma & Healthcare Global Biopharmaceuticals Contract Manufacturing Market Growth (Status and Outlook) 2021-2026

  • RnM4283983
  • |
  • 03 February, 2021
  • |
  • Global
  • |
  • 130 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
  • 2.1.1 Global Biopharmaceuticals Contract Manufacturing Market Size 2016-2026
  • 2.1.2 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Biopharmaceuticals Contract Manufacturing Segment by Product
  • 2.2.1 Biologics
  • 2.2.2 Biologics
  • 2.3 Biopharmaceuticals Contract Manufacturing Market Size by Product
  • 2.3.1 Global Biopharmaceuticals Contract Manufacturing Market Size CAGR by Product
  • 2.3.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Product (2016-2021)
  • 2.4 Biopharmaceuticals Contract Manufacturing Segment by Application
  • 2.4.1 Process Development
  • 2.4.2 Packaging
  • 2.4.3 Others
  • 2.5 Biopharmaceuticals Contract Manufacturing Market Size by Application
  • 2.5.1 Global Biopharmaceuticals Contract Manufacturing Market Size CAGR by Application
  • 2.5.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2016-2021)
  • 3 Biopharmaceuticals Contract Manufacturing Market Size by Players

    • 3.1 Biopharmaceuticals Contract Manufacturing Market Size Market Share by Players
    • 3.1.1 Global Biopharmaceuticals Contract Manufacturing Revenue by Players (2019-2021E)
  • 3.1.2 Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Biopharmaceuticals Contract Manufacturing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Biopharmaceuticals Contract Manufacturing by Regions

    • 4.1 Biopharmaceuticals Contract Manufacturing Market Size by Regions (2016-2021)
    • 4.2 Americas Biopharmaceuticals Contract Manufacturing Market Size Growth (2016-2021)
    • 4.3 APAC Biopharmaceuticals Contract Manufacturing Market Size Growth (2016-2021)
    • 4.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Growth (2016-2021)
    • 4.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Growth (2016-2021)

    5 Americas

    • 5.1 Americas Biopharmaceuticals Contract Manufacturing Market Size by Country (2016-2021)
    • 5.2 Americas Biopharmaceuticals Contract Manufacturing Market Size by Product (2016-2021)
    • 5.3 Americas Biopharmaceuticals Contract Manufacturing Market Size by Application (2016-2021)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil

    6 APAC

    • 6.1 APAC Biopharmaceuticals Contract Manufacturing Market Size by Region (2016-2021)
    • 6.2 APAC Biopharmaceuticals Contract Manufacturing Market Size by Product (2016-2021)
    • 6.3 APAC Biopharmaceuticals Contract Manufacturing Market Size by Application (2016-2021)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia

    7 Europe

    • 7.1 Europe Biopharmaceuticals Contract Manufacturing by Country (2016-2021)
    • 7.2 Europe Biopharmaceuticals Contract Manufacturing Market Size by Product (2016-2021)
    • 7.3 Europe Biopharmaceuticals Contract Manufacturing Market Size by Application (2016-2021)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia

    8 Middle East & Africa

    • 8.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing by Region (2016-2021)
    • 8.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Product (2016-2021)
    • 8.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Application (2016-2021)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries

    9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends
  • 10 Global Biopharmaceuticals Contract Manufacturing Market Forecast

    • 10.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2021-2026)
    • 10.1.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2021-2026)
  • 10.1.2 Americas Biopharmaceuticals Contract Manufacturing Forecast
  • 10.1.3 APAC Biopharmaceuticals Contract Manufacturing Forecast
  • 10.1.4 Europe Biopharmaceuticals Contract Manufacturing Forecast
  • 10.1.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast
  • 10.2 Americas Biopharmaceuticals Contract Manufacturing Forecast by Countries (2021-2026)
  • 10.2.1 United States Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.2.2 Canada Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.2.3 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.2.4 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3 APAC Biopharmaceuticals Contract Manufacturing Forecast by Region (2021-2026)
  • 10.3.1 China Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3.2 Japan Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3.3 Korea Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3.4 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3.5 India Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.3.6 Australia Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.4 Europe Biopharmaceuticals Contract Manufacturing Forecast by Country (2021-2026)
  • 10.4.1 Germany Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.4.2 France Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.4.3 UK Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.4.4 Italy Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.4.5 Russia Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast by Region (2021-2026)
  • 10.5.1 Egypt Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.5.2 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.5.3 Israel Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.5.4 Turkey Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.5.5 GCC Countries Biopharmaceuticals Contract Manufacturing Market Forecast
  • 10.6 Global Biopharmaceuticals Contract Manufacturing Forecast by Product (2021-2026)
  • 10.8 Global Biopharmaceuticals Contract Manufacturing Forecast by Application (2021-2026)
  • 11 Key Players Analysis

    • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Company Information
  • 11.1.2 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 Boehringer Ingelheim Main Business Overview
  • 11.1.5 Boehringer Ingelheim Latest Developments
  • 11.2 Lonza Group AG
  • 11.2.1 Lonza Group AG Company Information
  • 11.2.2 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 Lonza Group AG Main Business Overview
  • 11.2.5 Lonza Group AG Latest Developments
  • 11.3 Inno Biologics Sdn Bhd
  • 11.3.1 Inno Biologics Sdn Bhd Company Information
  • 11.3.2 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 Inno Biologics Sdn Bhd Main Business Overview
  • 11.3.5 Inno Biologics Sdn Bhd Latest Developments
  • 11.4 Rentschler Biopharma
  • 11.4.1 Rentschler Biopharma Company Information
  • 11.4.2 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 Rentschler Biopharma Main Business Overview
  • 11.4.5 Rentschler Biopharma Latest Developments
  • 11.5 JRS Pharma
  • 11.5.1 JRS Pharma Company Information
  • 11.5.2 JRS Pharma Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 JRS Pharma Main Business Overview
  • 11.5.5 JRS Pharma Latest Developments
  • 11.6 AGC Biologics
  • 11.6.1 AGC Biologics Company Information
  • 11.6.2 AGC Biologics Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 AGC Biologics Main Business Overview
  • 11.6.5 AGC Biologics Latest Developments
  • 11.7 ProBioGen
  • 11.7.1 ProBioGen Company Information
  • 11.7.2 ProBioGen Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 ProBioGen Main Business Overview
  • 11.7.5 ProBioGen Latest Developments
  • 11.8 FUJIFILM Diosynth Biotechnologies
  • 11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
  • 11.8.2 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
  • 11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
  • 11.9 Toyobo Co., Ltd.
  • 11.9.1 Toyobo Co., Ltd. Company Information
  • 11.9.2 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Toyobo Co., Ltd. Main Business Overview
  • 11.9.5 Toyobo Co., Ltd. Latest Developments
  • 11.10 Samsung Biologics
  • 11.10.1 Samsung Biologics Company Information
  • 11.10.2 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 Samsung Biologics Main Business Overview
  • 11.10.5 Samsung Biologics Latest Developments
  • 11. Thermo Fisher Scientific

    • 11.11.1 Thermo Fisher Scientific Company Information
  • 11.11.2 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Thermo Fisher Scientific Main Business Overview
  • 11.11.5 Thermo Fisher Scientific Latest Developments
  • 11.12 Binex Co., Ltd.
  • 11.12.1 Binex Co., Ltd. Company Information
  • 11.12.2 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.12.4 Binex Co., Ltd. Main Business Overview
  • 11.12.5 Binex Co., Ltd. Latest Developments
  • 11.13 WuXi Biologics
  • 11.13.1 WuXi Biologics Company Information
  • 11.13.2 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.13.4 WuXi Biologics Main Business Overview
  • 11.13.5 WuXi Biologics Latest Developments
  • 11.14 AbbVie, Inc.
  • 11.14.1 AbbVie, Inc. Company Information
  • 11.14.2 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product Offered
  • 11.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
  • 11.14.4 AbbVie, Inc. Main Business Overview
  • 11.14.5 AbbVie, Inc. Latest Developments
  • 12 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Biopharmaceuticals Contract Manufacturing will have significant change from previous year. By the most conservative estimates of global Biopharmaceuticals Contract Manufacturing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Biopharmaceuticals Contract Manufacturing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
    This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceuticals Contract Manufacturing market by product type, application, key players and key regions and countries.

    Segmentation by product: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

    Biologics

    Biosimilars

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

    Process Development

    Packaging

    Others

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

    Boehringer Ingelheim

    Lonza Group AG

    Inno Biologics Sdn Bhd

    Rentschler Biopharma

    JRS Pharma

    AGC Biologics

    ProBioGen

    FUJIFILM Diosynth Biotechnologies

    Toyobo Co., Ltd.

    Samsung Biologics

    Thermo Fisher Scientific

    Binex Co., Ltd.

    WuXi Biologics

    AbbVie, Inc.


    Summary:
    Get latest Market Research Reports on Biopharmaceuticals Contract Manufacturing. Industry analysis & Market Report on Biopharmaceuticals Contract Manufacturing is a syndicated market report, published as Global Biopharmaceuticals Contract Manufacturing Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Biopharmaceuticals Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,507.98
    5,015.96
    2,896.86
    5,793.73
    373,618.00
    747,236.00
    257,397.00
    514,794.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report